Search company, investor...

Founded Year

2005

Stage

Acquired | Acquired

Total Raised

$8.4M

About ForSight VISION4

ForSight Labs is a community of ophthalmic innovation focused on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients.

Headquarters Location

191 Jefferson Drive

Menlo Park, California, 94025,

United States

650-325-2050

Loading...

Loading...

ForSight VISION4 Patents

ForSight VISION4 has filed 67 patents.

The 3 most popular patent topics include:

  • diseases of the eye and adnexa
  • pharmacokinetics
  • ophthalmology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/14/2019

11/14/2023

Diseases of the eye and adnexa, Ophthalmology, Disorders of choroid and retina, Ophthalmology drugs, Dog diseases

Grant

Application Date

8/14/2019

Grant Date

11/14/2023

Title

Related Topics

Diseases of the eye and adnexa, Ophthalmology, Disorders of choroid and retina, Ophthalmology drugs, Dog diseases

Status

Grant

Latest ForSight VISION4 News

ForSight VISION4, Inc. Announces Acquisition by Roche

Jan 16, 2017

Announces Acquisition by Roche Next Story Prev Story 1 hr ago Read more: Vision Monday MENLO PARK, Calif.-ForSight VISION4, a privately held biotechnology company innovating drug delivery for treatment of retinal diseases, announced that it has been acquired by Roche Holdings Inc. The company is the fourth venture created by the Menlo Park incubator, ForSight Labs, LLC , and was funded entirely by two of the leading venture capital firms in Silicon Valley, Morgenthaler Ventures and Versant Ventures. The acquisition expands Roche's exclusive access to the ForSight VISION4 PDS technology for long acting delivery of therapeutics to the eye. Start the conversation, or Read more at Vision Monday.

ForSight VISION4 Frequently Asked Questions (FAQ)

  • When was ForSight VISION4 founded?

    ForSight VISION4 was founded in 2005.

  • Where is ForSight VISION4's headquarters?

    ForSight VISION4's headquarters is located at 191 Jefferson Drive, Menlo Park.

  • What is ForSight VISION4's latest funding round?

    ForSight VISION4's latest funding round is Acquired.

  • How much did ForSight VISION4 raise?

    ForSight VISION4 raised a total of $8.4M.

  • Who are the investors of ForSight VISION4?

    Investors of ForSight VISION4 include Roche, Morgenthaler Ventures, Split Rock Partners, Versant Ventures and The Foundry.

  • Who are ForSight VISION4's competitors?

    Competitors of ForSight VISION4 include Biolog, Biocytogen, Bloomage BioTech, Biodel, Seahorse Bioscience and 7 more.

Loading...

Compare ForSight VISION4 to Competitors

Biolog Logo
Biolog

Biolog is a company that specializes in microbial identification and characterization, operating within the biotechnology industry. The company offers products and services that enable the characterization of microbial and mammalian cells, as well as the identification of a wide range of bacteria, yeast, and fungi. Biolog primarily serves sectors such as bioprocess and fermentation, environmental monitoring and quality control, brewing, probiotics, drug discovery and diagnostics, and basic research. It was founded in 1984 and is based in Hayward, California.

P
Protherics plc

Protherics is an international biopharmaceutical company focused on specialist products for critical care and cancer.nThe Company has two critical care products, CroFab and DigiFab, approved for sale in the US. The Company has the opportunity to sell these products in the US from October 2010 together with Voraxaze, a supportive cancer care product, following anticipated approval in the US in 2010. Protherics is also developing a number of other products in the cancer arena that it can commercialise in-house.nIn addition, Protherics has several potential blockbuster products that require development and commercialisation partners. These include CytoFab which has been partnered by AstraZeneca in a major licensing deal, and also Angiotensin Therapeutic Vaccine and Digoxin Immune Fabs for which licensing partners will be sought in 2008-2009. These products have the potential to be high value products that can provide additional funding for the Company.n

Plexus Ventures Logo
Plexus Ventures

Plexus Ventures is a healthcare advisory boutique operating in the healthcare, pharma, medical devices, biotech, and consumer health sectors. The company offers strategic advisory services, managing long and time-consuming transactions, and provides structure to corporate and business development activities. Primarily, Plexus Ventures caters to healthcare companies of all sizes worldwide. It is based in Santa Monica, California.

d
deltaDOT

deltaDOT is a company focused on High Performance Capillary Electrophoresis (HPCE) within the life sciences research and diagnostics sectors. They design, manufacture, and market HPCE analytical instruments that utilize their proprietary Label Free Intrinsic Imaging technology for a wide range of biomolecular analyses. The company also provides analytical services and engages in scientific collaborations, primarily serving the biopharmaceutical manufacturing, drug testing, and veterinary diagnostics industries. It is based in United Kingdom.

S
Sensia Biosensing Solutions

April 2004, Sensia spun-off from the technologies developed at the Biosensor Group within the National Microelectronics Centre (CNM) of the Spanish National Research Council (CSIC). Concluding research results and availability of biosensing systems already working at lab level originated the proposal of bringing them into commercialisation, after an initial phase of prototyping and industrialisation. This first idea was supported by Genetrix a young biotech company which is interested in developing biosensors for the characterisation and detection of molecular interactions which are relevant in human pathologies. Dr. Pedro Banda, with experience in the semiconductor industry and biosensor technologies, joined in to get in charge of the project.n

B
Biomat

Biomat is an engineering company that focuses on surface-modified products for the In Vitro Diagnostics industry. The company offers a range of products including microplates and PCR products, which are used for immunoassays, research, and other applications in the diagnostic field. It was founded in 1992 and is based in Santa Margherita, Italy.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.